Dr. Wolters is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
513 parnassus ave
San Francisco, CA 94143Phone+1 415-353-4624Fax+1 415-353-2640
Education & Training
- University of California (San Francisco)Fellowship, Pulmonary Disease and Critical Care Medicine, 1998
- University of ColoradoResidency, Internal Medicine, 1992 - 1995
- University of Minnesota Medical SchoolClass of 1992
Certifications & Licensure
- CA State Medical License 1995 - 2026
- CO State Medical License 1994 - 1995
- American Board of Internal Medicine Critical Care Medicine
- American Board of Internal Medicine Pulmonary Disease
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Publications & Presentations
PubMed
- Molecular underpinnings of aging contributing to systemic sclerosis pathogenesis.Monica M Yang, Francesco Boin, Paul J Wolters
Current Opinion in Rheumatology. 2025-01-01 - Genotype and Other Common Variants are Associated with Computational Imaging Features of UIP.Rachel Z Blumhagen, Stephen M Humphries, Anna L Peljto, David A Lynch, Jonathan Cardwell
Annals of the American Thoracic Society. 2024-11-26 - Proteomic profiling of bronchoalveolar lavage fluid uncovers protein clusters linked to survival in idiopathic forms of interstitial lung disease.Linh T Ngo, Michaella J Rekowski, Devin C Koestler, Takafumi Yorozuya, Atsushi Saito
ERJ Open Research. 2024-11-01
Journal Articles
- MUC5B Promoter Variant and Rheumatoid Arthritis with Interstitial Lung DiseaseJay H Ryu, Deborah Assayag, Marvin I Schwarz, Paul Wolters, Andrew Gross, Ivan O Rosas, The New England Journal of Medicine
Press Mentions
- World's Leading Lung Disease Experts Join Numedii's Idiopathic Pulmonary Fibrosis Advisory BoardJanuary 8th, 2018
Grant Support
- Analysis Of Alveolar Type II Cells In Normal And Fibrotic Human LungNational Heart, Lung, And Blood Institute2011–2012
- MAST Cells And The Host Response In The LungNational Heart, Lung, And Blood Institute2004–2007
- MAST Cell Cysteine Proteases In Lung InflammationNational Heart, Lung, And Blood Institute1999–2003
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: